Search Tag: Blood Cancer

ICU Management

2023 07 Dec

Presented at the American Society of Hematology (ASH) 65th annual meeting   AOP Orphan Pharmaceuticals GmbH (AOP Health), Vienna, Austria, announced the results of an analysis assessing the impact of an individually optimized dosing regimen of ropeginterferon alfa-2b on treatment response in patients with low-risk polycythemia vera (PV) 1  These...Read more

Executive Health Management

2023 06 Sep

Read more